ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 165 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,510,490 | +12.2% | 1,001,000 | +8.8% | 1.52% | +7.3% |
| Q2 2023 | $18,280,400 | +16.0% | 920,000 | 0.0% | 1.41% | +35.9% |
| Q1 2023 | $15,759,600 | -5.3% | 920,000 | +8.2% | 1.04% | +0.1% |
| Q4 2022 | $16,634,500 | +64.7% | 850,000 | +34.3% | 1.04% | +115.6% |
| Q3 2022 | $10,100,000 | +16.0% | 632,822 | 0.0% | 0.48% | +12.4% |
| Q2 2022 | $8,708,000 | -10.4% | 632,822 | +3.3% | 0.43% | -16.4% |
| Q1 2022 | $9,719,000 | -27.4% | 612,822 | 0.0% | 0.51% | -19.0% |
| Q4 2021 | $13,378,000 | -16.2% | 612,822 | +14.7% | 0.63% | -23.4% |
| Q3 2021 | $15,964,000 | – | 534,085 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $11,354,000 | 10.44% |
| RTW INVESTMENTS, LP | 15,802,802 | $250,632,000 | 5.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 63,000 | $17,884,000 | 4.03% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,077,000 | 4.02% |
| Prosight Management, LP | 203,268 | $3,224,000 | 2.08% |
| COWEN AND COMPANY, LLC | 1,000,000 | $15,860,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,252,000 | 1.20% |
| Cormorant Asset Management, LP | 868,550 | $13,775,000 | 1.06% |
| Amitell Capital Pte Ltd | 97,331 | $1,544,000 | 0.90% |
| SECTORAL ASSET MANAGEMENT INC | 303,975 | $4,821,000 | 0.86% |